The following table shows the list of Horizon 2020 projects developed by "ABBVIE INC". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | BEAt-DKD | H2020-EU.3.1.7. | participant | 0.00 | 2016-09-01 | 1482 |
2 | HARMONY | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 949 |
3 | EQIPD | H2020-EU.3.1.7. | participant | 0.00 | 2017-10-01 | 808 |
4 | eTRANSAFE | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 906 |
5 | EFOEUPATI | H2020-EU.3.1.7. | participant | 0.00 | 2018-09-01 | 314 |
6 | WEB-RADR 2 | H2020-EU.3.1.7. | participant | 0.00 | 2018-09-01 | 338 |
7 | EHDEN | H2020-EU.3.1.7. | participant | 0.00 | 2018-11-01 | 358 |
8 | ArthritisHeal | H2020-EU.1.3.1. | partner | 0.00 | 2019-03-01 | 353 |
9 | IMMUcan | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 351 |
10 | ConcePTION | H2020-EU.3.1.7. | participant | 0.00 | 2019-04-01 | 378 |
11 | IDEA-FAST | H2020-EU.3.1.7. | participant | 0.00 | 2019-11-01 | 338 |
12 | PharmaLedger | H2020-EU.3.1.7. | participant | 0.00 | 2020-01-01 | 409 |
totale | 0.00 |
This organization collaborated with partners in 26 countries.
Within the project BEAt-DKD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | JDRF | JDRF INTERNATIONAL (REC) |
participant | DE | Lipotype | LIPOTYPE (PRC) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | FR | CHUB | CHU HOPITAUX DE BORDEAUX (HES) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | IT | IRFMN | ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (REC) |
participant | IT | UBA | UNIVERSITA DEGLI STUDI DI BARI ALDO MORO (HES) |
participant | US | UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN (HES) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
participant | UK | UNEXE | THE UNIVERSITY OF EXETER (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | DE | UKLFR | UNIVERSITAETSKLINIKUM FREIBURG (HES) |
participant | DE | RCI | KLINIKUM DER UNIVERSITAET REGENSBURG (HES) |
coordinator | SE | LU | LUNDS UNIVERSITET (HES) |
participant | FI | UTU | TURUN YLIOPISTO (HES) |
participant | UK | UHULL | UNIVERSITY OF HULL (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | UK | UoB | UNIVERSITY OF BRISTOL (HES) |
participant | UK | UNIVLEEDS | UNIVERSITY OF LEEDS (HES) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
Within the project HARMONY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LYSA | THE LYMPHOMA STUDY ASSOCIATION (REC) |
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | FR | GRAALL | GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (REC) |
participant | DE | GPOH | GPOH GEMEINNUTZIGE GMBH (REC) |
participant | IT | FISMonlus | FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS (REC) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | DE | ERIC | EUROPEAN RESEARCH INITIATIVE ON CLL EV (REC) |
participant | NL | EHA | EUROPEAN HEMATOLOGY ASSOCIATION (OTH) |
participant | BE | EAPM | EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL (REC) |
participant | DE | ELN Foundation | STIFTUNG ELN FOUNDATION (OTH) |
participant | IT | Menarini | MENARINI RICERCHE SPA (PRC) |
participant | ES | IJC | FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS (REC) |
coordinator | ES | IECSCYL | FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON (REC) |
participant | FI | MS | MEDISAPIENS OY (PRC) |
participant | FR | GFM | GROUPE FRANCOPHONE DES MYELODYSPLASIES (REC) |
participant | UK | Takeda EU | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | LeukaNET | LEUKANET EV (OTH) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | DE | MLL | MLL MUNCHNER LEUKAMIELABOR GMBH (PRC) |
participant | NL | EBMT | EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION (OTH) |
participant | ES | VHIO | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC) |
participant | ES | HULAFE | FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (REC) |
participant | ES | GMV | GMV SOLUCIONES GLOBALES INTERNET SAU (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | UK | BHT | BARTS AND THE LONDON NHS TRUST (REC) |
participant | DE | BfArM | BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE (PUB) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | IT | OPBG | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | AEMPS | AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (PUB) |
participant | ES | UNAV | UNIVERSIDAD DE NAVARRA (HES) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | BE | VIB | VIB (REC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | URTV | UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA (HES) |
participant | DE | UDUS | HEINRICH-HEINE-UNIVERSITAET DUESSELDORF (HES) |
participant | IT | UNITO | UNIVERSITA DEGLI STUDI DI TORINO (HES) |
participant | CZ | MU | Masarykova univerzita (HES) |
participant | DE | UULM | UNIVERSITAET ULM (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | UK | UoY | UNIVERSITY OF YORK (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | DE | IAP | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN (HES) |
participant | UK | GRL | GENOME RESEARCH LIMITED (REC) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
participant | FI | UHEL | HELSINGIN YLIOPISTO (HES) |
Within the project EQIPD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Arlenda | PHARMALEX BELGIUM (PRC) |
participant | US | SE | SCIENCE EXCHANGE, INC. (PRC) |
participant | BE | Arlenda | ARLENDA SA (PRC) |
participant | DE | PAASP | PAASP GMBH (PRC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | US | PGI | PSYCHOGENICS INC (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | FR | Porsolt | PORSOLT SAS (PRC) |
participant | DE | UMC-Mainz | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | NOLDUS | NOLDUS INFORMATION TECHNOLOGY BV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | NL | Sylics | SYNAPTOLOGICS BV (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | UK | UniAbdn | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (HES) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
coordinator | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | CH | UBERN | UNIVERSITAET BERN (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project eTRANSAFE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | JP | Eisai | EISAI CO LTD (PRC) |
participant | UK | Clarivate | CLARIVATE ANALYTICS (UK) LIMITED (PRC) |
participant | UK | PDS | PDS COMPUTER SOFTWARE LIMITED (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | UK | OPTIBRIUM | OPTIBRIUM LIMITED (PRC) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | UK | LL | LHASA LIMITED (REC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | MN | MOLECULAR NETWORKS GMBH COMPUTERCHEMIE (PRC) |
participant | UK | LJMU | LIVERPOOL JOHN MOORES UNIVERSITY (HES) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
coordinator | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | ES | UPF | UNIVERSIDAD POMPEU FABRA (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project EFOEUPATI this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IE | IPPOSI | IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE (OTH) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
Within the project WEB-RADR 2 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | SNOMED | INTERNATIONAL HEALTH TERMINOLOGY STANDARDS DEVELOPMENT ORGANISATION (OTH) |
participant | CH | ICH | THE INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE (OTH) |
participant | DK | DKMA | LAEGEMIDDELSTYRELSEN (PUB) |
participant | DE | CSL | CSL BEHRING GMBH (PRC) |
coordinator | UK | MHRA | MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (PUB) |
participant | NL | LAREB | STICHTING LAREB (REC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | ES | AEMPS | AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (PUB) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
Within the project EHDEN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CZ | Odysseus | ODYSSEUS DATA SERVICES SRO (PRC) |
participant | UK | ICHOM | INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT LTD (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | NL | THE HYVE | THE HYVE BV (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | PT | UAVR | UNIVERSIDADE DE AVEIRO (HES) |
participant | EE | TARTU | TARTU ULIKOOL (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project ArthritisHeal this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | NL | IAK Nederland - Institute for Applied Creativity Matthias Dehne | DEHNE MATTHIAS (PRC) |
partner | CA | SCIEX | AB Sciex Pte. Ltd (PRC) |
participant | EL | PhG | PHARMAGNOSE VIOTECHNOLOGIKI ANONYMI ETAIREIA (PRC) |
partner | NL | Reumafonds | STICHTING NATIONAAL REUMAFONDS (OTH) |
participant | FR | BC | IMMUNOTECH SAS (PRC) |
partner | UK | PHARMATICS LIMITED | PHARMATICS LIMITED (PRC) |
partner | US | SCRIPPS | THE SCRIPPS RESEARCH INSTITUTE (HES) |
partner | US | UC | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (HES) |
partner | EL | UoA | ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | UK | UGLA | UNIVERSITY OF GLASGOW (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | CU | CARDIFF UNIVERSITY (HES) |
coordinator | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
Within the project IMMUcan this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LCC | LIGUE NATIONALE CONTRE LE CANCER (REC) |
participant | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | IJB | INSTITUT JULES BORDET (HES) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | BE | DDUV | DE DUVE INSTITUTE (REC) |
participant | FR | PIERRE FABRE | INSTITUT DE RECHERCHE PIERRE FABRESAS (PRC) |
participant | FR | CLB | CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | FR | IC | INSTITUT CURIE (REC) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project ConcePTION this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | ORC | ORCION BV (PRC) |
participant | BE | Bionotus | BIONOTUS (PRC) |
participant | NL | ENTIS | STICHTING ENTIS (EUROPEAN NETWORK TERATOLOGY INFORMATION SERVICES) FOUNDATION (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | DK | Ellegaard | ELLEGAARD GOTTINGEN MINIPIGS AS (PRC) |
participant | BE | i-HD | THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (REC) |
participant | IL | Teva | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | UK | MHRA | MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (PUB) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | NL | Elevate | ELEVATE BV (PRC) |
participant | AT | BBMRI-ERIC | BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC) (REC) |
participant | NL | TTOP | TTOPSTART BV (PRC) |
participant | ES | FISABIO | FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | FI | THL | TERVEYDEN JA HYVINVOINNIN LAITOS (REC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | IE | EIWH | EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE (REC) |
participant | NL | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
participant | NL | LAREB | STICHTING LAREB (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | SE | SCC | REGION STOCKHOLM (PUB) |
participant | UK | NUTH | THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST (PUB) |
participant | IT | ARS | AGENZIA REGIONALE DI SANITA (OTH) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | IT | UNIFE | UNIVERSITA DEGLI STUDI DI FERRARA (HES) |
participant | UK | USWAN | SWANSEA UNIVERSITY (HES) |
participant | UK | SGUL | ST GEORGE'S HOSPITAL MEDICAL SCHOOL (HES) |
participant | UK | Ulster | UNIVERSITY OF ULSTER (HES) |
participant | ZA | UKZN | UNIVERSITY OF KWAZULU-NATAL (HES) |
participant | FR | CHUT | CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
coordinator | NL | UMC UTRECHT | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UNIGE | UNIVERSITE DE GENEVE (HES) |
participant | NO | UiO | UNIVERSITETET I OSLO (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | IT | CNR | CONSIGLIO NAZIONALE DELLE RICERCHE (REC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | NL | RIVM | RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (REC) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project IDEA-FAST this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | MBS | MEDIBIOSENSE LTD (PRC) |
participant | BE | BYTE | BYTEFLIES (PRC) |
participant | PT | FC.ID | FCIENCIAS.ID - ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS (REC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | IT | PLUR | PLURIBUS ONE SRL (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | BE | EFCCA | EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (OTH) |
participant | FI | VTT | Teknologian tutkimuskeskus VTT Oy (REC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | DE | GHI | GEORGE-HUNTINGTON-INSTITUT GMBH (PRC) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | PUK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | FR | LIXOFT | LIXOFT SAS (PRC) |
participant | ES | APM | ASOCIACION PARKINSON MADRID (OTH) |
participant | NL | McR | MCROBERTS BV (PRC) |
participant | UK | TAK | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | CCL | CAMBRIDGE COGNITION LIMITED (PRC) |
participant | NO | SUH | HELSE STAVANGER HF (OTH) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | PL | IPIN | INSTYTUT PSYCHIATRII I NEUROLOGII (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | DE | EMP | EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH (PRC) |
participant | IE | UL | UNIVERSITY OF LIMERICK (HES) |
participant | PT | IMM | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (REC) |
participant | DE | UKSH | UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | FR | IMT | INSTITUT MINES-TELECOM (HES) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | ES | UAM | UNIVERSIDAD AUTONOMA DE MADRID (HES) |
participant | IT | UNIBS | UNIVERSITA DEGLI STUDI DI BRESCIA (HES) |
participant | UK | UoM | THE UNIVERSITY OF MANCHESTER (HES) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | UK | UGLAS | UNIVERSITY OF GLASGOW (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | UK | ICL | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project PharmaLedger this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | PT | HES | HOSPITAL DO ESPIRITO SANTO DE EVORA EPE (PUB) |
participant | PT | INCM | IMPRENSA NACIONAL - CASA DA MOEDA, S. A. (PRC) |
participant | DE | BAYER | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IL | AVO | ARTEEVO TECHNOLOGIES LTD (PRC) |
participant | UK | TVS | TECHNOVATIVE SOLUTIONS LTD (PRC) |
participant | UK | ONO | ONORACH LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | IL | EKN | EKON MODELING SOFWARE SYSTEMS LTD*EKON (PRC) |
participant | IT | OPB | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | RO | INCDTCI ICSI | NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CRYOGENICS AND ISOTOPIC TECHNOLOGIES ICSI RM VALCEA (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | EL | DUT | DIMOKRITIO PANEPISTIMIO THRAKIS (HES) |
participant | PT | PDM | PDM E FC PROJECTO DESENVOLVIMENTO MANUTENCAO FORMACAO E CONSULTADORIALDA (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | RO | RMS | ROMSOFT SRL (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
coordinator | ES | UPM | UNIVERSIDAD POLITECNICA DE MADRID (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |